pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4500 |
Genomic Coordinates | chr13: 87618665 - 87618740 |
Description | Homo sapiens miR-4500 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4500 | |||||||||||||||||||||
Sequence | 54| UGAGGUAGUAGUUUCUU |70 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | GRPEL2 | ||||||||||||||||||||
Synonyms | Mt-GrpE#2 | ||||||||||||||||||||
Description | GrpE like 2, mitochondrial | ||||||||||||||||||||
Transcript | NM_152407 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on GRPEL2 | |||||||||||||||||||||
3'UTR of GRPEL2 (miRNA target sites are highlighted) |
>GRPEL2|NM_152407|3'UTR 1 AGAGGCCATCAGGAACTGGATGTTCTCCCAGAGCGCAGTCACCTATGTTTCTTTTATTTATTAAACTAGGTTTGTATTGT 81 ACATGAGGTACTTCATGTGATATGTTTTGGATTTAGTCATATTGGCTTTATTTCTAAGATATTCTATTGATTTAATGTGA 161 CCTGTTTGGTCTCATCAGAAGTCTTACCATTGGGCATTTGAACAGTGTGACAGGTGTTCCAATGGCCTTTATCAAAACAT 241 GTTTAGGAAAATTGGTACTGTGATAAATTTGAATCCAAAATCCTTTTAACTATGGGTTTTCAACTACATGTTTCTTCCTA 321 GCGGTCTCTATAACAGGAATTGTGTAGTATCTTGTATTTTGTGGAAAAAGGAGATGGTAGGGATTGGTTCAACATTTGGG 401 TACTTAGAGGATAAAGCTTCGTGGTCGTATAAATTTAGATCATTTGGATTGATTTTTATACACATAGATTTTCAGGACTT 481 TACCTTTTGTTTTGTTTTTTTCCTTTTAGCCATCTTTTGTTCTTGTAATCCCAACTAGATAGGCTTTATGCTCACATCAT 561 TGTCCCATACCCACCCCTTTCTCATCCCCATTTGCAGGGGCTAAAGGTCTAGATGAGACTTGGAAGGCAAGGAGCATCGA 641 AATTTGAGATACCCAGGACCCTTTCAAGCAAGAATGGCCAAAAAGCCTTGTGCTGTCTTTGCTCTTCAAATTATTTTCAG 721 CCTCCTTGTCATATAATCATTTCAGGCAAACTGAGGCAACACTAACAGCTAATGACCCAGATGGCTCTATTTGGGTAATT 801 TACCTACAACTTATTCCACCAGCCTTTACTCCTCTGCCCTTTTGTCAATTTTACCTTATAATCCTTTATTAAATGATGGG 881 AGGTGGTGATCAGGACAAAAGTGTTAGGTTCCCATGATTTCTCATTTCATTTATTAATAGTTAATGCTGAATTTTTTTTT 961 AAGTTTCCTCTGGCTCTATTTATGTTACTTTTTGCGATAAGAACACTTAACATAAGTATTCTCTCCTCTTGGCAATTTTT 1041 TTTTTTTTTCCTGTGTTGCCCAGGCTGACCTCCAACTCCTGGGCCCAAGCAATCCTGCCTCAGCCTGCCAAGTAGCTAGG 1121 ACTACAGGCGTTCACCACTGCGCCCGCAAAGTTTTTTTGTTGTTTTTTTTTTTAAGTTGGTACTCACAAATCACTACCTC 1201 TGTTATATTGACAAGCTCTATTTCCTATTCTTTGTATCTGTTAAGTCACATCTGTGTAAACATTGAGCTCACCTTTTATA 1281 TATTAACCTCTAGAATTAATGGGCCTATGTGGTTTTTTTTCAGTCTTATAGCTGGTGTTCTGTAAAAGATTTGTCCAATA 1361 AACGACTTAATGAATGATACATCAGTCAGATTTTAGGAAGGCAGTCAATTATGGATATTTTAATGTTGGAAGAGGCCTTA 1441 ATGATCAAATCTCACCCTTTCTGCTTCTGAAGTATGAAAATCTAGTCTTTTTAGGACTGGACACAAGGAAAATAATCTCT 1521 AAACTATTGACTAAATTCCAGTGAGAGTATGAATGAAGAACAACTAGATATTAATGTCAATCATTTAAGATTAATGGGCA 1601 TGCAATTAAGTCTCCATTTAAGATTAATGGGCATGCAATGAAGTCTCCAGCAGACAATCAGATGTTGTTGGATGTCTAGA 1681 TTATATAGGTTTAGGTTGAAGTTATAAAATAAAATAAAATTCATTTTCCACTGGAACTCTATGACATTCAGTGGAGTGGT 1761 GGAAAGTTAACCTCTTATACATTATAGATAATTCTAAGACAGCACACAAACTTATCAATAAAGCCATCTCCTTGTGGGCC 1841 TTACCATCTTCATCAGATTTAGACCCTTAAAAAACAAGTAAATATGCACTTTTAAAATGCAATCAAAAGACTGGTGGTTA 1921 AGCTTGTAAAACCAGAACATCTTTTGGCATTCCACTAAGTATATATTGTAAATTTAATGAACAATCAAGGTTCACAATAG 2001 GAAGTTGTCTTTTTTTGCCTTCCATTCTGTGAGATTTGACAGATGGTGACAATAAGAAAATGAGCTGATTGTAATTACTC 2081 TCTGTGTGTTTTTTTATTGCTAGCTATCATTACCAGTTAGAATTAACATTAATTACAATTAACAATAATTTTAGGTATGG 2161 AATGTTATGATTACCTAAAGAGATGTCTCTACCTAATGAGCTCAAGTGATCCTCCCACCTCAGCCTACCAAGTAGCCAGG 2241 ACCACAGGCAAGTGCACCACCATGACTGGCTAGTTTTGTTTTTTGGTTTTTGGTTTTTGGTTTTTGGTTTTTTTTTTTTG 2321 GTTGGTTGGTTGTTTTTTACAGGCGGGGTCTCACTATATTGTCCAGGCTAGAAGAATTTTCTAATGGTCTATTACACCTC 2401 CCGTTTTGGCAAGTAAATTCAGAATAATTTTAGGTTCTTTTGTTATTCAGTAGTTTTGCAGACTTAAAAGTGTAAATTTA 2481 GAATTAGAAGATGAAGCTATAGTAGTAAGAATCTCAAGCTGAAGGGCTTTGGGGAGCCAAAGCAGCATATTAGAGCATAG 2561 GCTTGAACTTAAATCTCAGCTCAGTCACCTGCAGGACTTTAGGCACCAGTGATTTCACCCTTCTGAGCCTGTTTCTTTAT 2641 TCGTAAAATGATTATAATAATTCTTTCACAGCGTTGTGAGGATTAAGTGAAATGTGTTAAATGCCTACTACAGTAGGTGC 2721 TCAGATATTTATTTTTATTTTTTTATTATGCACATTGTTTTTCCTGCCTTTTTATGGCTGTCTAAAGTCTAGGGAAAAGG 2801 GAAGACTGGTTAATGATGAGTAGAAAAAACTTGTAAGCTAATCATTCACTGACTTATTTTCCTTCCATTTTCTGGTTTTT 2881 AAAATTAGCCACACCACAGGAAACCCACATTTTTAGATGGAAAGAGCAAGAAAATTGTGTCAGTGCTCTTAGTTATTTTC 2961 ATCTTAATGGTATAGTGAAAAGACATTGACTTGAGATGATACTAAGGAAGCTTTGGCTCACTCTCACTTGAAGAGGGGAT 3041 CTTGGTGTTGTAGTACTTGGACTGTACAAATGTTTTACTGACTTTTCTTACTGCTGTAAAGGAATCAGGCAGTTGGGTAT 3121 TGATATGTTATTTGGTGCTCTCATTCATGGCAAAGGATTTGATAAATAAAAGTTCTTTAAACACTAAAGCAAAATCAAAT 3201 GAGCAAAACTAAGGATGAAATGTAATATTCATCAGAACAAGGATCACTGAGAAAAAATATTCAGAAACAACTTTAATAAA 3281 ACCTGAATTGAAATAACTGCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 134266.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 134266.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 5 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
Experimental Support 6 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177599. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_1
PAR-CLIP data was present in ERX177603. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_5
PAR-CLIP data was present in ERX177606. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_2_8
PAR-CLIP data was present in ERX177607. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_2_9
PAR-CLIP data was present in ERX177608. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_10
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177623. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_1
PAR-CLIP data was present in ERX177627. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_4_5
PAR-CLIP data was present in ERX177630. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_8
PAR-CLIP data was present in ERX177604. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_2_6
PAR-CLIP data was present in ERX177620. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_10
PAR-CLIP data was present in ERX177628. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_6
PAR-CLIP data was present in ERX177632. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_10
PAR-CLIP data was present in ERX177616. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_6
PAR-CLIP data was present in ERX177600. RNA binding protein: AGO2. Condition:p53_V_Ago_CLIP_2_2
PAR-CLIP data was present in ERX177612. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_3_2
PAR-CLIP data was present in ERX177624. RNA binding protein: AGO2. Condition:p53_V_AGO_CLIP_4_2
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_152407 | 3UTR | UAAGUUGGUACUCACAAAUCACUACCUCUGUUAUAUUGACAAGCUCUAUUUCCUAUUCUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_152407 | 3UTR | UACUCACAAAUCACUACCUCUGUUAUAUUGACAAGCUCUAUUUCCUAUUCUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_152407 | 3UTR | ACUCACAAAUCACUACCUCUGUUAUAUUGACAAGCUCUAUUUCCUAUUCUUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUGUUAUAUUGAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUGUUAUAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000329271.3 | 3UTR | ACUCACAAAUCACUACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUGUUAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUGUUAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000329271.3 | 3UTR | UACUCACAAAUCACUACCUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT063205 | ADIPOR2 | adiponectin receptor 2 | 2 | 2 | ||||||||
MIRT065701 | ESPL1 | extra spindle pole bodies like 1, separase | 2 | 4 | ||||||||
MIRT066489 | HMGA2 | high mobility group AT-hook 2 | 2 | 4 | ||||||||
MIRT067415 | TMTC3 | transmembrane and tetratricopeptide repeat containing 3 | 2 | 2 | ||||||||
MIRT068169 | TXLNA | taxilin alpha | 2 | 2 | ||||||||
MIRT068540 | NHLRC3 | NHL repeat containing 3 | 2 | 6 | ||||||||
MIRT068798 | FNDC3A | fibronectin type III domain containing 3A | 2 | 2 | ||||||||
MIRT073020 | ARID3B | AT-rich interaction domain 3B | 2 | 6 | ||||||||
MIRT073683 | IGF1R | insulin like growth factor 1 receptor | 2 | 8 | ||||||||
MIRT076241 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 6 | ||||||||
MIRT077628 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT080409 | ONECUT2 | one cut homeobox 2 | 2 | 2 | ||||||||
MIRT083315 | ZCCHC3 | zinc finger CCHC-type containing 3 | 2 | 2 | ||||||||
MIRT084989 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT094172 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT094475 | SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 2 | 4 | ||||||||
MIRT095781 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 10 | ||||||||
MIRT100105 | ABT1 | activator of basal transcription 1 | 2 | 8 | ||||||||
MIRT112254 | MDM4 | MDM4, p53 regulator | 2 | 4 | ||||||||
MIRT118595 | STK4 | serine/threonine kinase 4 | 2 | 2 | ||||||||
MIRT120932 | PDE12 | phosphodiesterase 12 | 2 | 8 | ||||||||
MIRT123336 | CALU | calumenin | 2 | 2 | ||||||||
MIRT123991 | POLR3D | RNA polymerase III subunit D | 2 | 2 | ||||||||
MIRT152317 | TNFSF9 | TNF superfamily member 9 | 2 | 2 | ||||||||
MIRT153921 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT168608 | HMGA1 | high mobility group AT-hook 1 | 2 | 4 | ||||||||
MIRT180614 | CRY2 | cryptochrome circadian clock 2 | 2 | 2 | ||||||||
MIRT187726 | SUOX | sulfite oxidase | 2 | 2 | ||||||||
MIRT191415 | NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | 2 | 2 | ||||||||
MIRT193113 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT215732 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 10 | ||||||||
MIRT218822 | CDKN1A | cyclin dependent kinase inhibitor 1A | 2 | 2 | ||||||||
MIRT240344 | UBXN2B | UBX domain protein 2B | 2 | 2 | ||||||||
MIRT243480 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT244088 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT252341 | SALL3 | spalt like transcription factor 3 | 2 | 2 | ||||||||
MIRT255327 | CDV3 | CDV3 homolog | 2 | 2 | ||||||||
MIRT259295 | PGRMC1 | progesterone receptor membrane component 1 | 2 | 2 | ||||||||
MIRT259499 | TXLNG | taxilin gamma | 2 | 2 | ||||||||
MIRT260715 | CLDN12 | claudin 12 | 2 | 6 | ||||||||
MIRT264701 | C11ORF57 | chromosome 11 open reading frame 57 | 2 | 4 | ||||||||
MIRT266228 | PEX11B | peroxisomal biogenesis factor 11 beta | 2 | 2 | ||||||||
MIRT266635 | CHTOP | chromatin target of PRMT1 | 2 | 2 | ||||||||
MIRT268847 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 2 | ||||||||
MIRT284540 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT294453 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT297023 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT297451 | SLC20A1 | solute carrier family 20 member 1 | 2 | 4 | ||||||||
MIRT300049 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 4 | ||||||||
MIRT300907 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 2 | ||||||||
MIRT303328 | MXD1 | MAX dimerization protein 1 | 2 | 2 | ||||||||
MIRT309858 | NAT8L | N-acetyltransferase 8 like | 2 | 2 | ||||||||
MIRT322434 | PPP2R2A | protein phosphatase 2 regulatory subunit Balpha | 2 | 2 | ||||||||
MIRT324742 | ACER2 | alkaline ceramidase 2 | 2 | 2 | ||||||||
MIRT402068 | ATP6V1F | ATPase H+ transporting V1 subunit F | 2 | 4 | ||||||||
MIRT442014 | NDUFA4P1 | NDUFA4, mitochondrial complex associated pseudogene 1 | 2 | 2 | ||||||||
MIRT445653 | ATP6V1G1 | ATPase H+ transporting V1 subunit G1 | 2 | 6 | ||||||||
MIRT447131 | KIF27 | kinesin family member 27 | 2 | 2 | ||||||||
MIRT448262 | ZNF774 | zinc finger protein 774 | 2 | 2 | ||||||||
MIRT449002 | ANKRD46 | ankyrin repeat domain 46 | 2 | 2 | ||||||||
MIRT449949 | FMNL3 | formin like 3 | 2 | 2 | ||||||||
MIRT451150 | C19orf53 | chromosome 19 open reading frame 53 | 2 | 2 | ||||||||
MIRT451620 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | 2 | 2 | ||||||||
MIRT451689 | C1RL | complement C1r subcomponent like | 2 | 2 | ||||||||
MIRT452087 | NUCB2 | nucleobindin 2 | 2 | 2 | ||||||||
MIRT452427 | QDPR | quinoid dihydropteridine reductase | 2 | 2 | ||||||||
MIRT452938 | DISC1 | disrupted in schizophrenia 1 | 2 | 2 | ||||||||
MIRT453397 | RHD | Rh blood group D antigen | 2 | 6 | ||||||||
MIRT454159 | HIST1H2BK | histone cluster 1 H2B family member k | 2 | 2 | ||||||||
MIRT454275 | FXN | frataxin | 2 | 2 | ||||||||
MIRT454535 | RABL2A | RAB, member of RAS oncogene family like 2A | 2 | 2 | ||||||||
MIRT454849 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 4 | ||||||||
MIRT455671 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT457243 | RABL2B | RAB, member of RAS oncogene family like 2B | 2 | 2 | ||||||||
MIRT457671 | ZNF587 | zinc finger protein 587 | 2 | 2 | ||||||||
MIRT457882 | THEM6 | thioesterase superfamily member 6 | 2 | 4 | ||||||||
MIRT458012 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT458275 | FUT10 | fucosyltransferase 10 | 2 | 2 | ||||||||
MIRT459732 | RRM1 | ribonucleotide reductase catalytic subunit M1 | 2 | 2 | ||||||||
MIRT460447 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 4 | ||||||||
MIRT460495 | FAM105A | family with sequence similarity 105 member A | 2 | 6 | ||||||||
MIRT460933 | NOA1 | nitric oxide associated 1 | 2 | 4 | ||||||||
MIRT461088 | OPA3 | OPA3, outer mitochondrial membrane lipid metabolism regulator | 2 | 2 | ||||||||
MIRT461164 | SLC11A2 | solute carrier family 11 member 2 | 2 | 4 | ||||||||
MIRT461360 | COL8A1 | collagen type VIII alpha 1 chain | 2 | 2 | ||||||||
MIRT462377 | YAE1D1 | Yae1 domain containing 1 | 2 | 2 | ||||||||
MIRT462775 | ZNF8 | zinc finger protein 8 | 2 | 2 | ||||||||
MIRT463426 | ZC3HAV1L | zinc finger CCCH-type containing, antiviral 1 like | 2 | 2 | ||||||||
MIRT463656 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT464260 | VCL | vinculin | 2 | 2 | ||||||||
MIRT465121 | TSC22D2 | TSC22 domain family member 2 | 2 | 4 | ||||||||
MIRT466190 | TMED5 | transmembrane p24 trafficking protein 5 | 2 | 4 | ||||||||
MIRT466728 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT469098 | RNF144B | ring finger protein 144B | 2 | 2 | ||||||||
MIRT469718 | RAB40C | RAB40C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT470422 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | 2 | 2 | ||||||||
MIRT470684 | POLR2D | RNA polymerase II subunit D | 2 | 4 | ||||||||
MIRT470866 | PLXND1 | plexin D1 | 2 | 2 | ||||||||
MIRT471269 | PGM2L1 | phosphoglucomutase 2 like 1 | 2 | 2 | ||||||||
MIRT471960 | NR6A1 | nuclear receptor subfamily 6 group A member 1 | 2 | 2 | ||||||||
MIRT472677 | NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | 2 | 2 | ||||||||
MIRT472735 | MTUS1 | microtubule associated scaffold protein 1 | 2 | 6 | ||||||||
MIRT473132 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT473237 | SMCR7L | mitochondrial elongation factor 1 | 2 | 5 | ||||||||
MIRT473824 | MAP2K7 | mitogen-activated protein kinase kinase 7 | 2 | 2 | ||||||||
MIRT473935 | LYN | LYN proto-oncogene, Src family tyrosine kinase | 2 | 2 | ||||||||
MIRT474020 | LRRC20 | leucine rich repeat containing 20 | 2 | 2 | ||||||||
MIRT474504 | KLHDC8B | kelch domain containing 8B | 2 | 2 | ||||||||
MIRT474762 | KIAA0930 | KIAA0930 | 2 | 2 | ||||||||
MIRT474912 | KCTD21 | potassium channel tetramerization domain containing 21 | 2 | 2 | ||||||||
MIRT475327 | IFNLR1 | interferon lambda receptor 1 | 2 | 2 | ||||||||
MIRT475374 | ICOSLG | inducible T-cell costimulator ligand | 2 | 2 | ||||||||
MIRT475729 | HERPUD1 | homocysteine inducible ER protein with ubiquitin like domain 1 | 2 | 4 | ||||||||
MIRT476544 | GABPB1 | GA binding protein transcription factor beta subunit 1 | 2 | 4 | ||||||||
MIRT476982 | FAM83G | family with sequence similarity 83 member G | 2 | 4 | ||||||||
MIRT477539 | EIF4G2 | eukaryotic translation initiation factor 4 gamma 2 | 2 | 4 | ||||||||
MIRT477676 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT479751 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT481189 | ATXN7L3B | ataxin 7 like 3B | 2 | 4 | ||||||||
MIRT481235 | ATXN7L3 | ataxin 7 like 3 | 2 | 2 | ||||||||
MIRT481358 | ATG9A | autophagy related 9A | 2 | 2 | ||||||||
MIRT481383 | ATG12 | autophagy related 12 | 2 | 2 | ||||||||
MIRT481647 | AREL1 | apoptosis resistant E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT481843 | AP1S1 | adaptor related protein complex 1 sigma 1 subunit | 2 | 2 | ||||||||
MIRT482179 | AHR | aryl hydrocarbon receptor | 2 | 2 | ||||||||
MIRT482215 | AHCYL2 | adenosylhomocysteinase like 2 | 2 | 2 | ||||||||
MIRT485301 | PLAGL2 | PLAG1 like zinc finger 2 | 2 | 2 | ||||||||
MIRT486654 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT489409 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT491861 | ZBTB5 | zinc finger and BTB domain containing 5 | 2 | 8 | ||||||||
MIRT492217 | SOCS1 | suppressor of cytokine signaling 1 | 2 | 2 | ||||||||
MIRT492632 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 2 | ||||||||
MIRT493320 | LIMD2 | LIM domain containing 2 | 2 | 2 | ||||||||
MIRT493897 | FAM43A | family with sequence similarity 43 member A | 2 | 4 | ||||||||
MIRT494259 | CEP120 | centrosomal protein 120 | 2 | 2 | ||||||||
MIRT494681 | ARID3A | AT-rich interaction domain 3A | 2 | 2 | ||||||||
MIRT495963 | TBC1D19 | TBC1 domain family member 19 | 2 | 2 | ||||||||
MIRT496117 | SNX17 | sorting nexin 17 | 2 | 2 | ||||||||
MIRT497870 | SLC12A7 | solute carrier family 12 member 7 | 2 | 2 | ||||||||
MIRT498115 | PLEKHO1 | pleckstrin homology domain containing O1 | 2 | 4 | ||||||||
MIRT499400 | PLCG2 | phospholipase C gamma 2 | 2 | 4 | ||||||||
MIRT499489 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 2 | 2 | ||||||||
MIRT499648 | SDR42E1 | short chain dehydrogenase/reductase family 42E, member 1 | 2 | 2 | ||||||||
MIRT499937 | MFSD8 | major facilitator superfamily domain containing 8 | 2 | 2 | ||||||||
MIRT499993 | HIST1H2BD | histone cluster 1 H2B family member d | 2 | 4 | ||||||||
MIRT500821 | THBS1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT500900 | STRN | striatin | 2 | 4 | ||||||||
MIRT501111 | SLC5A6 | solute carrier family 5 member 6 | 2 | 4 | ||||||||
MIRT501179 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT501206 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT501249 | SEMA4C | semaphorin 4C | 2 | 6 | ||||||||
MIRT501334 | RNFT1 | ring finger protein, transmembrane 1 | 2 | 2 | ||||||||
MIRT501357 | RNF44 | ring finger protein 44 | 2 | 4 | ||||||||
MIRT501394 | RBFOX2 | RNA binding protein, fox-1 homolog 2 | 2 | 10 | ||||||||
MIRT501437 | RAB11FIP4 | RAB11 family interacting protein 4 | 2 | 2 | ||||||||
MIRT501749 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT501939 | MBD2 | methyl-CpG binding domain protein 2 | 2 | 8 | ||||||||
MIRT502104 | KPNA5 | karyopherin subunit alpha 5 | 2 | 8 | ||||||||
MIRT502123 | KMT2D | lysine methyltransferase 2D | 2 | 4 | ||||||||
MIRT502787 | CEP135 | centrosomal protein 135 | 2 | 2 | ||||||||
MIRT502839 | CELF1 | CUGBP Elav-like family member 1 | 2 | 2 | ||||||||
MIRT504783 | C12orf4 | chromosome 12 open reading frame 4 | 2 | 2 | ||||||||
MIRT505020 | ZNF644 | zinc finger protein 644 | 2 | 2 | ||||||||
MIRT505577 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT506359 | NUP155 | nucleoporin 155 | 2 | 6 | ||||||||
MIRT506936 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | 2 | 6 | ||||||||
MIRT507248 | FIGN | fidgetin, microtubule severing factor | 2 | 8 | ||||||||
MIRT507691 | COIL | coilin | 2 | 6 | ||||||||
MIRT508397 | C1orf210 | chromosome 1 open reading frame 210 | 2 | 6 | ||||||||
MIRT508660 | DIABLO | diablo IAP-binding mitochondrial protein | 2 | 4 | ||||||||
MIRT508927 | AK4 | adenylate kinase 4 | 2 | 4 | ||||||||
MIRT510387 | ZNF566 | zinc finger protein 566 | 2 | 6 | ||||||||
MIRT510521 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT511381 | IKZF3 | IKAROS family zinc finger 3 | 2 | 4 | ||||||||
MIRT512740 | CD59 | CD59 molecule (CD59 blood group) | 2 | 4 | ||||||||
MIRT515949 | C9orf156 | tRNA methyltransferase O | 2 | 2 | ||||||||
MIRT516078 | ZBTB8OS | zinc finger and BTB domain containing 8 opposite strand | 2 | 4 | ||||||||
MIRT521392 | RDX | radixin | 2 | 4 | ||||||||
MIRT522344 | NCKIPSD | NCK interacting protein with SH3 domain | 2 | 4 | ||||||||
MIRT523623 | FZD9 | frizzled class receptor 9 | 2 | 4 | ||||||||
MIRT523728 | FBXW2 | F-box and WD repeat domain containing 2 | 2 | 4 | ||||||||
MIRT523981 | DVL3 | dishevelled segment polarity protein 3 | 2 | 2 | ||||||||
MIRT524108 | DNA2 | DNA replication helicase/nuclease 2 | 2 | 2 | ||||||||
MIRT525722 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT527758 | RRAD | RRAD, Ras related glycolysis inhibitor and calcium channel regulator | 2 | 2 | ||||||||
MIRT529722 | OPRL1 | opioid related nociceptin receptor 1 | 2 | 2 | ||||||||
MIRT533183 | WASL | Wiskott-Aldrich syndrome like | 2 | 6 | ||||||||
MIRT536373 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT543781 | RBM12B | RNA binding motif protein 12B | 2 | 4 | ||||||||
MIRT543863 | SLC16A9 | solute carrier family 16 member 9 | 2 | 2 | ||||||||
MIRT545383 | PM20D2 | peptidase M20 domain containing 2 | 2 | 2 | ||||||||
MIRT545895 | ZNF200 | zinc finger protein 200 | 2 | 4 | ||||||||
MIRT546328 | TGFBR3 | transforming growth factor beta receptor 3 | 2 | 2 | ||||||||
MIRT547374 | MSI2 | musashi RNA binding protein 2 | 2 | 2 | ||||||||
MIRT547577 | LRIG3 | leucine rich repeats and immunoglobulin like domains 3 | 2 | 4 | ||||||||
MIRT547834 | IGF2BP3 | insulin like growth factor 2 mRNA binding protein 3 | 2 | 4 | ||||||||
MIRT548260 | FBXL20 | F-box and leucine rich repeat protein 20 | 2 | 2 | ||||||||
MIRT548342 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT548539 | DUSP1 | dual specificity phosphatase 1 | 2 | 2 | ||||||||
MIRT548554 | DNAL1 | dynein axonemal light chain 1 | 2 | 2 | ||||||||
MIRT548787 | COLEC12 | collectin subfamily member 12 | 2 | 2 | ||||||||
MIRT548976 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT549026 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT549213 | BEND4 | BEN domain containing 4 | 2 | 4 | ||||||||
MIRT549759 | ZNF611 | zinc finger protein 611 | 2 | 6 | ||||||||
MIRT549794 | KIAA0391 | KIAA0391 | 2 | 2 | ||||||||
MIRT549843 | ECHDC1 | ethylmalonyl-CoA decarboxylase 1 | 2 | 2 | ||||||||
MIRT550723 | PMPCA | peptidase, mitochondrial processing alpha subunit | 2 | 4 | ||||||||
MIRT550893 | ACTA1 | actin, alpha 1, skeletal muscle | 2 | 2 | ||||||||
MIRT551277 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | 2 | 6 | ||||||||
MIRT551313 | GSG2 | histone H3 associated protein kinase | 2 | 6 | ||||||||
MIRT551928 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT551998 | RAD18 | RAD18, E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT552405 | ZNF460 | zinc finger protein 460 | 2 | 4 | ||||||||
MIRT553016 | USP38 | ubiquitin specific peptidase 38 | 2 | 2 | ||||||||
MIRT555544 | PLEKHA3 | pleckstrin homology domain containing A3 | 2 | 2 | ||||||||
MIRT555716 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT557377 | HAND1 | heart and neural crest derivatives expressed 1 | 2 | 2 | ||||||||
MIRT557957 | FAM222B | family with sequence similarity 222 member B | 2 | 2 | ||||||||
MIRT559086 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 4 | ||||||||
MIRT559493 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT561777 | PEG10 | paternally expressed 10 | 2 | 2 | ||||||||
MIRT564396 | EMILIN2 | elastin microfibril interfacer 2 | 2 | 4 | ||||||||
MIRT565445 | SURF4 | surfeit 4 | 2 | 2 | ||||||||
MIRT566514 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT567437 | GNG5 | G protein subunit gamma 5 | 2 | 2 | ||||||||
MIRT567712 | E2F6 | E2F transcription factor 6 | 2 | 2 | ||||||||
MIRT568652 | ABHD17C | abhydrolase domain containing 17C | 2 | 2 | ||||||||
MIRT569493 | THYN1 | thymocyte nuclear protein 1 | 2 | 2 | ||||||||
MIRT573816 | TGOLN2 | trans-golgi network protein 2 | 2 | 2 | ||||||||
MIRT574358 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT574754 | GOLGA4 | golgin A4 | 2 | 2 | ||||||||
MIRT574791 | FAM104A | family with sequence similarity 104 member A | 2 | 2 | ||||||||
MIRT576081 | Poteg | POTE ankyrin domain family, member G | 2 | 2 | ||||||||
MIRT576813 | Thbs1 | thrombospondin 1 | 2 | 3 | ||||||||
MIRT616365 | RWDD1 | RWD domain containing 1 | 2 | 2 | ||||||||
MIRT617846 | FMO4 | flavin containing monooxygenase 4 | 2 | 2 | ||||||||
MIRT642389 | ZNF556 | zinc finger protein 556 | 2 | 2 | ||||||||
MIRT680514 | PRIM2 | DNA primase subunit 2 | 2 | 2 | ||||||||
MIRT680542 | ZNF584 | zinc finger protein 584 | 2 | 2 | ||||||||
MIRT680795 | ZNF578 | zinc finger protein 578 | 2 | 2 | ||||||||
MIRT680833 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT681136 | INTS7 | integrator complex subunit 7 | 2 | 2 | ||||||||
MIRT681266 | RFC2 | replication factor C subunit 2 | 2 | 2 | ||||||||
MIRT681318 | ZFAND4 | zinc finger AN1-type containing 4 | 2 | 4 | ||||||||
MIRT681354 | BRI3BP | BRI3 binding protein | 2 | 2 | ||||||||
MIRT681501 | STAT2 | signal transducer and activator of transcription 2 | 2 | 2 | ||||||||
MIRT681531 | ZNF738 | zinc finger protein 738 | 2 | 2 | ||||||||
MIRT681653 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 2 | ||||||||
MIRT681733 | RAB19 | RAB19, member RAS oncogene family | 2 | 4 | ||||||||
MIRT681756 | CDKAL1 | CDK5 regulatory subunit associated protein 1 like 1 | 2 | 2 | ||||||||
MIRT681792 | EIF4A3 | eukaryotic translation initiation factor 4A3 | 2 | 2 | ||||||||
MIRT681864 | DNAH9 | dynein axonemal heavy chain 9 | 2 | 2 | ||||||||
MIRT681936 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT682097 | ITGA3 | integrin subunit alpha 3 | 2 | 4 | ||||||||
MIRT682177 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT682233 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT682379 | PHACTR4 | phosphatase and actin regulator 4 | 2 | 2 | ||||||||
MIRT682439 | MTX3 | metaxin 3 | 2 | 2 | ||||||||
MIRT682599 | CPA4 | carboxypeptidase A4 | 2 | 2 | ||||||||
MIRT682635 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 2 | ||||||||
MIRT689323 | FPR1 | formyl peptide receptor 1 | 2 | 2 | ||||||||
MIRT689725 | ATXN2 | ataxin 2 | 2 | 2 | ||||||||
MIRT691031 | ZNF799 | zinc finger protein 799 | 2 | 2 | ||||||||
MIRT691930 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 2 | ||||||||
MIRT694879 | ZNF417 | zinc finger protein 417 | 2 | 2 | ||||||||
MIRT695250 | ZNF443 | zinc finger protein 443 | 2 | 2 | ||||||||
MIRT695408 | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide | 2 | 2 | ||||||||
MIRT700593 | PRSS22 | protease, serine 22 | 2 | 2 | ||||||||
MIRT701434 | NHLRC2 | NHL repeat containing 2 | 2 | 2 | ||||||||
MIRT702479 | KIAA1328 | KIAA1328 | 2 | 2 | ||||||||
MIRT702716 | IPO9 | importin 9 | 2 | 2 | ||||||||
MIRT704036 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT704415 | CTPS1 | CTP synthase 1 | 2 | 2 | ||||||||
MIRT705745 | AMD1 | adenosylmethionine decarboxylase 1 | 2 | 2 | ||||||||
MIRT712369 | NAP1L1 | nucleosome assembly protein 1 like 1 | 2 | 2 | ||||||||
MIRT713515 | PAFAH2 | platelet activating factor acetylhydrolase 2 | 2 | 2 | ||||||||
MIRT735773 | STAT3 | signal transducer and activator of transcription 3 | 6 | 1 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|